Genetic Medicine Delivery Enhanced by Producer Cell Modifications
Researchers at the Whitehead Institute have developed a platform to enhance the delivery of gene editing tools using engineered virus-like particles (eVLPs). These particles can enter human cells without carrying viral genes, making them suitable for therapeutic applications. The study, published in Nature Communications, identifies genes that influence the production of these particles, allowing for more efficient delivery. By disabling certain genes, researchers improved the production of guide RNAs and the potency of the delivery vehicles. This advancement could significantly enhance the application of gene editing technologies. 
